Corvus Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Burlingame, CA, dedicated to developing innovative medicines for cancer and immune diseases. With a strong focus on ITK (interleukin-2-inducible T-cell kinase) inhibition, their platform opportunity holds great promise for improving the lives of patients.
Driven by a passion for scientific advancement, Corvus Pharmaceuticals is led by a team of experienced professionals who are committed to pushing the boundaries of medical research. Through their cutting-edge approach and robust pipeline, the company aims to make significant contributions to the field of oncology and immunology.
Generated from the website